SF3B1 and myelodysplastic syndrome: The introduction of SF3B1 gene mutation in the criteria of diagnosis of MDS with ring sideroblasts and the identification of Clonal Hematopoiesis of Indeterminate Potential (CHIP), an entity without clear MDS features but with gene mutations commonly seen in MDS in the 2016 revision, reflected the great importance of the molecular characteristics (11).